APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bendamustine Hydrochloride for Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Bendamustine Hydrochloride for Injection Industry Research Report 2026

Report ID 173969670522 December 2025127 pages

Choose your research edition.

Industry ResearchBendamustine Hydrochloride for Injection Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Bendamustine Hydrochloride for Injection Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Bendamustine Hydrochloride for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bendamustine Hydrochloride for Injection Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Bendamustine Hydrochloride for Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bendamustine Hydrochloride for Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Bendamustine Hydrochloride for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Bendamustine Hydrochloride for Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Bendamustine Hydrochloride for Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Bendamustine Hydrochloride for Injection include Apotex, Cephalon, Dr. Reddy's Laboratories, Viatris, Baxter, Fresenius Kabi, Kindos Pharma, Nang Kuang Pharmaceutical and Sichuan Huiyu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Bendamustine Hydrochloride for Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Bendamustine Hydrochloride for Injection Market by Company

Apotex

Cephalon

Dr. Reddy's Laboratories

Viatris

Baxter

Fresenius Kabi

Kindos Pharma

Nang Kuang Pharmaceutical

Sichuan Huiyu Pharmaceutical

Jiangsu Simcere Pharmaceutical

Yangtze River Pharmaceutical Group

Chia Tai Tianqing Pharmaceutical

Bendamustine Hydrochloride for Injection Segment by Type

25mg/Pcs

100mg/Pcs

Bendamustine Hydrochloride for Injection Segment by Application

Hospitals

Clinics

Others

Bendamustine Hydrochloride for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bendamustine Hydrochloride for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bendamustine Hydrochloride for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bendamustine Hydrochloride for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Bendamustine Hydrochloride for Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Bendamustine Hydrochloride for Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Bendamustine Hydrochloride for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Bendamustine Hydrochloride for Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Bendamustine Hydrochloride for Injection Sales (k units) of Manufacturers (2021-2026) Table 7. Global Bendamustine Hydrochloride for Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Bendamustine Hydrochloride for Injection Revenue of Manufacturers (2021-2026) Table 9. Global Bendamustine Hydrochloride for Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Bendamustine Hydrochloride for Injection Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Bendamustine Hydrochloride for Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Bendamustine Hydrochloride for Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Bendamustine Hydrochloride for Injection, Product Type & Application Table 14. Global Bendamustine Hydrochloride for Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Bendamustine Hydrochloride for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Apotex Company Information Table 19. Apotex Business Overview Table 20. Apotex Bendamustine Hydrochloride for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Apotex Bendamustine Hydrochloride for Injection Product Portfolio Table 22. Apotex Recent Developments Table 23. Cephalon Company Information Table 24. Cephalon Business Overview Table 25. Cephalon Bendamustine Hydrochloride for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Cephalon Bendamustine Hydrochloride for Injection Product Portfolio Table 27. Cephalon Recent Developments Table 28. Dr. Reddy's Laboratories Company Information Table 29. Dr. Reddy's Laboratories Business Overview Table 30. Dr. Reddy's Laboratories Bendamustine Hydrochloride for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Dr. Reddy's Laboratories Bendamustine Hydrochloride for Injection Product Portfolio Table 32. Dr. Reddy's Laboratories Recent Developments Table 33. Viatris Company Information Table 34. Viatris Business Overview Table 35. Viatris Bendamustine Hydrochloride for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Viatris Bendamustine Hydrochloride for Injection Product Portfolio Table 37. Viatris Recent Developments Table 38. Baxter Company Information Table 39. Baxter Business Overview Table 40. Baxter Bendamustine Hydrochloride for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Baxter Bendamustine Hydrochloride for Injection Product Portfolio Table 42. Baxter Recent Developments Table 43. Fresenius Kabi Company Information Table 44. Fresenius Kabi Business Overview Table 45. Fresenius Kabi Bendamustine Hydrochloride for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Fresenius Kabi Bendamustine Hydrochloride for Injection Product Portfolio Table 47. Fresenius Kabi Recent Developments Table 48. Kindos Pharma Company Information Table 49. Kindos Pharma Business Overview Table 50. Kindos Pharma Bendamustine Hydrochloride for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Kindos Pharma Bendamustine Hydrochloride for Injection Product Portfolio Table 52. Kindos Pharma Recent Developments Table 53. Nang Kuang Pharmaceutical Company Information Table 54. Nang Kuang Pharmaceutical Business Overview Table 55. Nang Kuang Pharmaceutical Bendamustine Hydrochloride for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Nang Kuang Pharmaceutical Bendamustine Hydrochloride for Injection Product Portfolio Table 57. Nang Kuang Pharmaceutical Recent Developments Table 58. Sichuan Huiyu Pharmaceutical Company Information Table 59. Sichuan Huiyu Pharmaceutical Business Overview Table 60. Sichuan Huiyu Pharmaceutical Bendamustine Hydrochloride for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Sichuan Huiyu Pharmaceutical Bendamustine Hydrochloride for Injection Product Portfolio Table 62. Sichuan Huiyu Pharmaceutical Recent Developments Table 63. Jiangsu Simcere Pharmaceutical Company Information Table 64. Jiangsu Simcere Pharmaceutical Business Overview Table 65. Jiangsu Simcere Pharmaceutical Bendamustine Hydrochloride for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Jiangsu Simcere Pharmaceutical Bendamustine Hydrochloride for Injection Product Portfolio Table 67. Jiangsu Simcere Pharmaceutical Recent Developments Table 68. Yangtze River Pharmaceutical Group Company Information Table 69. Yangtze River Pharmaceutical Group Business Overview Table 70. Yangtze River Pharmaceutical Group Bendamustine Hydrochloride for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Yangtze River Pharmaceutical Group Bendamustine Hydrochloride for Injection Product Portfolio Table 72. Yangtze River Pharmaceutical Group Recent Developments Table 73. Chia Tai Tianqing Pharmaceutical Company Information Table 74. Chia Tai Tianqing Pharmaceutical Business Overview Table 75. Chia Tai Tianqing Pharmaceutical Bendamustine Hydrochloride for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Chia Tai Tianqing Pharmaceutical Bendamustine Hydrochloride for Injection Product Portfolio Table 77. Chia Tai Tianqing Pharmaceutical Recent Developments Table 78. Global Bendamustine Hydrochloride for Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Bendamustine Hydrochloride for Injection Sales by Region (2021-2026) & (k units) Table 80. Global Bendamustine Hydrochloride for Injection Sales Market Share by Region (2021-2026) Table 81. Global Bendamustine Hydrochloride for Injection Sales by Region (2027-2032) & (k units) Table 82. Global Bendamustine Hydrochloride for Injection Sales Market Share by Region (2027-2032) Table 83. Global Bendamustine Hydrochloride for Injection Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Bendamustine Hydrochloride for Injection Revenue Market Share by Region (2021-2026) Table 85. Global Bendamustine Hydrochloride for Injection Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Bendamustine Hydrochloride for Injection Revenue Market Share by Region (2027-2032) Table 87. North America Bendamustine Hydrochloride for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Bendamustine Hydrochloride for Injection Sales by Country (2021-2026) & (k units) Table 89. North America Bendamustine Hydrochloride for Injection Sales by Country (2027-2032) & (k units) Table 90. North America Bendamustine Hydrochloride for Injection Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Bendamustine Hydrochloride for Injection Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Bendamustine Hydrochloride for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Bendamustine Hydrochloride for Injection Sales by Country (2021-2026) & (k units) Table 94. Europe Bendamustine Hydrochloride for Injection Sales by Country (2027-2032) & (k units) Table 95. Europe Bendamustine Hydrochloride for Injection Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Bendamustine Hydrochloride for Injection Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Bendamustine Hydrochloride for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Bendamustine Hydrochloride for Injection Sales by Country (2021-2026) & (k units) Table 99. Asia Pacific Bendamustine Hydrochloride for Injection Sales by Country (2027-2032) & (k units) Table 100. Asia Pacific Bendamustine Hydrochloride for Injection Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Bendamustine Hydrochloride for Injection Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Bendamustine Hydrochloride for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Bendamustine Hydrochloride for Injection Sales by Country (2021-2026) & (k units) Table 104. South America Bendamustine Hydrochloride for Injection Sales by Country (2027-2032) & (k units) Table 105. South America Bendamustine Hydrochloride for Injection Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Bendamustine Hydrochloride for Injection Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Bendamustine Hydrochloride for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Bendamustine Hydrochloride for Injection Sales by Country (2021-2026) & (k units) Table 109. Middle East and Africa Bendamustine Hydrochloride for Injection Sales by Country (2027-2032) & (k units) Table 110. Middle East and Africa Bendamustine Hydrochloride for Injection Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Bendamustine Hydrochloride for Injection Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Bendamustine Hydrochloride for Injection Sales by Type (2021-2026) & (k units) Table 113. Global Bendamustine Hydrochloride for Injection Sales by Type (2027-2032) & (k units) Table 114. Global Bendamustine Hydrochloride for Injection Sales Market Share by Type (2021-2026) Table 115. Global Bendamustine Hydrochloride for Injection Sales Market Share by Type (2027-2032) Table 116. Global Bendamustine Hydrochloride for Injection Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Bendamustine Hydrochloride for Injection Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Bendamustine Hydrochloride for Injection Revenue Market Share by Type (2021-2026) Table 119. Global Bendamustine Hydrochloride for Injection Revenue Market Share by Type (2027-2032) Table 120. Global Bendamustine Hydrochloride for Injection Price by Type (2021-2026) & (US$/unit) Table 121. Global Bendamustine Hydrochloride for Injection Price by Type (2027-2032) & (US$/unit) Table 122. Global Bendamustine Hydrochloride for Injection Sales by Application (2021-2026) & (k units) Table 123. Global Bendamustine Hydrochloride for Injection Sales by Application (2027-2032) & (k units) Table 124. Global Bendamustine Hydrochloride for Injection Sales Market Share by Application (2021-2026) Table 125. Global Bendamustine Hydrochloride for Injection Sales Market Share by Application (2027-2032) Table 126. Global Bendamustine Hydrochloride for Injection Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Bendamustine Hydrochloride for Injection Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Bendamustine Hydrochloride for Injection Revenue Market Share by Application (2021-2026) Table 129. Global Bendamustine Hydrochloride for Injection Revenue Market Share by Application (2027-2032) Table 130. Global Bendamustine Hydrochloride for Injection Price by Application (2021-2026) & (US$/unit) Table 131. Global Bendamustine Hydrochloride for Injection Price by Application (2027-2032) & (US$/unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Bendamustine Hydrochloride for Injection Distributors List Table 135. Bendamustine Hydrochloride for Injection Customers List Table 136. Bendamustine Hydrochloride for Injection Industry Trends Table 137. Bendamustine Hydrochloride for Injection Industry Drivers Table 138. Bendamustine Hydrochloride for Injection Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Bendamustine Hydrochloride for Injection Product Image Figure 5. Global Bendamustine Hydrochloride for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Bendamustine Hydrochloride for Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Bendamustine Hydrochloride for Injection Sales (2021-2032) & (k units) Figure 8. Global Bendamustine Hydrochloride for Injection Average Price (US$/unit) & (2021-2032) Figure 9. 25mg/Pcs Product Image Figure 10. 100mg/Pcs Product Image Figure 11. Hospitals Product Image Figure 12. Clinics Product Image Figure 13. Others Product Image Figure 14. Global Bendamustine Hydrochloride for Injection Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Bendamustine Hydrochloride for Injection, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Bendamustine Hydrochloride for Injection Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Bendamustine Hydrochloride for Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Bendamustine Hydrochloride for Injection Sales by Region in 2025 Figure 20. Global Bendamustine Hydrochloride for Injection Revenue by Region in 2025 Figure 21. North America Bendamustine Hydrochloride for Injection Market Size by Country in 2025 Figure 22. North America Bendamustine Hydrochloride for Injection Sales Market Share by Country (2021-2032) Figure 23. North America Bendamustine Hydrochloride for Injection Revenue Market Share by Country (2021-2032) Figure 24. United States Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Bendamustine Hydrochloride for Injection Market Size by Country in 2025 Figure 28. Europe Bendamustine Hydrochloride for Injection Sales Market Share by Country (2021-2032) Figure 29. Europe Bendamustine Hydrochloride for Injection Revenue Market Share by Country (2021-2032) Figure 30. Germany Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Bendamustine Hydrochloride for Injection Market Size by Country in 2025 Figure 41. Asia Pacific Bendamustine Hydrochloride for Injection Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Bendamustine Hydrochloride for Injection Revenue Market Share by Country (2021-2032) Figure 43. China Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Bendamustine Hydrochloride for Injection Market Size by Country in 2025 Figure 52. South America Bendamustine Hydrochloride for Injection Sales Market Share by Country (2021-2032) Figure 53. South America Bendamustine Hydrochloride for Injection Revenue Market Share by Country (2021-2032) Figure 54. Brazil Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Bendamustine Hydrochloride for Injection Market Size by Country in 2025 Figure 58. Middle East and Africa Bendamustine Hydrochloride for Injection Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Bendamustine Hydrochloride for Injection Revenue Market Share by Country (2021-2032) Figure 60. Egypt Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Bendamustine Hydrochloride for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Bendamustine Hydrochloride for Injection Sales Market Share by Type (2021-2032) Figure 66. Global Bendamustine Hydrochloride for Injection Revenue Market Share by Type (2021-2032) Figure 67. Global Bendamustine Hydrochloride for Injection Price (US$/unit) by Type (2021-2032) Figure 68. Global Bendamustine Hydrochloride for Injection Sales Market Share by Application (2021-2032) Figure 69. Global Bendamustine Hydrochloride for Injection Revenue Market Share by Application (2021-2032) Figure 70. Global Bendamustine Hydrochloride for Injection Price (US$/unit) by Application (2021-2032) Figure 71. Bendamustine Hydrochloride for Injection Value Chain Figure 72. Bendamustine Hydrochloride for Injection Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Bendamustine Hydrochloride for Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • 25mg/Pcs
  • 100mg/Pcs
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Apotex
  • Cephalon
  • Dr. Reddy's Laboratories
  • Viatris
  • Baxter
  • Fresenius Kabi
  • Kindos Pharma
  • Nang Kuang Pharmaceutical
  • Sichuan Huiyu Pharmaceutical
  • Jiangsu Simcere Pharmaceutical
  • Yangtze River Pharmaceutical Group
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Bendamustine Hydrochloride for Injection Market Size (2021-2032)
  4. 2.2.2 Global Bendamustine Hydrochloride for Injection Sales (2021-2032)
  5. 2.2.3 Global Bendamustine Hydrochloride for Injection Market Average Price (2021-2032)
  6. 2.3 Bendamustine Hydrochloride for Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 25mg/Pcs
  9. 2.3.3 100mg/Pcs
  10. 2.4 Bendamustine Hydrochloride for Injection by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospitals
  13. 2.4.3 Clinics
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Bendamustine Hydrochloride for Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Bendamustine Hydrochloride for Injection Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Bendamustine Hydrochloride for Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Bendamustine Hydrochloride for Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Bendamustine Hydrochloride for Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Bendamustine Hydrochloride for Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Bendamustine Hydrochloride for Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Bendamustine Hydrochloride for Injection, Established Date
  9. 3.9 Global Bendamustine Hydrochloride for Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Apotex
  2. 4.1.1 Apotex Company Information
  3. 4.1.2 Apotex Business Overview
  4. 4.1.3 Apotex Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Apotex Bendamustine Hydrochloride for Injection Product Portfolio
  6. 4.1.5 Apotex Recent Developments
  7. 4.2 Cephalon
  8. 4.2.1 Cephalon Company Information
  9. 4.2.2 Cephalon Business Overview
  10. 4.2.3 Cephalon Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Cephalon Bendamustine Hydrochloride for Injection Product Portfolio
  12. 4.2.5 Cephalon Recent Developments
  13. 4.3 Dr. Reddy's Laboratories
  14. 4.3.1 Dr. Reddy's Laboratories Company Information
  15. 4.3.2 Dr. Reddy's Laboratories Business Overview
  16. 4.3.3 Dr. Reddy's Laboratories Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Dr. Reddy's Laboratories Bendamustine Hydrochloride for Injection Product Portfolio
  18. 4.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 4.4 Viatris
  20. 4.4.1 Viatris Company Information
  21. 4.4.2 Viatris Business Overview
  22. 4.4.3 Viatris Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Viatris Bendamustine Hydrochloride for Injection Product Portfolio
  24. 4.4.5 Viatris Recent Developments
  25. 4.5 Baxter
  26. 4.5.1 Baxter Company Information
  27. 4.5.2 Baxter Business Overview
  28. 4.5.3 Baxter Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Baxter Bendamustine Hydrochloride for Injection Product Portfolio
  30. 4.5.5 Baxter Recent Developments
  31. 4.6 Fresenius Kabi
  32. 4.6.1 Fresenius Kabi Company Information
  33. 4.6.2 Fresenius Kabi Business Overview
  34. 4.6.3 Fresenius Kabi Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Fresenius Kabi Bendamustine Hydrochloride for Injection Product Portfolio
  36. 4.6.5 Fresenius Kabi Recent Developments
  37. 4.7 Kindos Pharma
  38. 4.7.1 Kindos Pharma Company Information
  39. 4.7.2 Kindos Pharma Business Overview
  40. 4.7.3 Kindos Pharma Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Kindos Pharma Bendamustine Hydrochloride for Injection Product Portfolio
  42. 4.7.5 Kindos Pharma Recent Developments
  43. 4.8 Nang Kuang Pharmaceutical
  44. 4.8.1 Nang Kuang Pharmaceutical Company Information
  45. 4.8.2 Nang Kuang Pharmaceutical Business Overview
  46. 4.8.3 Nang Kuang Pharmaceutical Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Nang Kuang Pharmaceutical Bendamustine Hydrochloride for Injection Product Portfolio
  48. 4.8.5 Nang Kuang Pharmaceutical Recent Developments
  49. 4.9 Sichuan Huiyu Pharmaceutical
  50. 4.9.1 Sichuan Huiyu Pharmaceutical Company Information
  51. 4.9.2 Sichuan Huiyu Pharmaceutical Business Overview
  52. 4.9.3 Sichuan Huiyu Pharmaceutical Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Sichuan Huiyu Pharmaceutical Bendamustine Hydrochloride for Injection Product Portfolio
  54. 4.9.5 Sichuan Huiyu Pharmaceutical Recent Developments
  55. 4.10 Jiangsu Simcere Pharmaceutical
  56. 4.10.1 Jiangsu Simcere Pharmaceutical Company Information
  57. 4.10.2 Jiangsu Simcere Pharmaceutical Business Overview
  58. 4.10.3 Jiangsu Simcere Pharmaceutical Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Jiangsu Simcere Pharmaceutical Bendamustine Hydrochloride for Injection Product Portfolio
  60. 4.10.5 Jiangsu Simcere Pharmaceutical Recent Developments
  61. 4.11 Yangtze River Pharmaceutical Group
  62. 4.11.1 Yangtze River Pharmaceutical Group Company Information
  63. 4.11.2 Yangtze River Pharmaceutical Group Business Overview
  64. 4.11.3 Yangtze River Pharmaceutical Group Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Yangtze River Pharmaceutical Group Bendamustine Hydrochloride for Injection Product Portfolio
  66. 4.11.5 Yangtze River Pharmaceutical Group Recent Developments
  67. 4.12 Chia Tai Tianqing Pharmaceutical
  68. 4.12.1 Chia Tai Tianqing Pharmaceutical Company Information
  69. 4.12.2 Chia Tai Tianqing Pharmaceutical Business Overview
  70. 4.12.3 Chia Tai Tianqing Pharmaceutical Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Chia Tai Tianqing Pharmaceutical Bendamustine Hydrochloride for Injection Product Portfolio
  72. 4.12.5 Chia Tai Tianqing Pharmaceutical Recent Developments
5 Global Bendamustine Hydrochloride for Injection Market Scenario by Region
  1. 5.1 Global Bendamustine Hydrochloride for Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Bendamustine Hydrochloride for Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Bendamustine Hydrochloride for Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Bendamustine Hydrochloride for Injection Sales by Region: 2027-2032
  5. 5.3 Global Bendamustine Hydrochloride for Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Bendamustine Hydrochloride for Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Bendamustine Hydrochloride for Injection Revenue by Region: 2027-2032
  8. 5.4 North America Bendamustine Hydrochloride for Injection Market Facts & Figures by Country
  9. 5.4.1 North America Bendamustine Hydrochloride for Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Bendamustine Hydrochloride for Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Bendamustine Hydrochloride for Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Bendamustine Hydrochloride for Injection Market Facts & Figures by Country
  16. 5.5.1 Europe Bendamustine Hydrochloride for Injection Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Bendamustine Hydrochloride for Injection Sales by Country (2021-2032)
  18. 5.5.3 Europe Bendamustine Hydrochloride for Injection Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Bendamustine Hydrochloride for Injection Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Bendamustine Hydrochloride for Injection Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Bendamustine Hydrochloride for Injection Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Bendamustine Hydrochloride for Injection Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Bendamustine Hydrochloride for Injection Market Facts & Figures by Country
  41. 5.7.1 South America Bendamustine Hydrochloride for Injection Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Bendamustine Hydrochloride for Injection Sales by Country (2021-2032)
  43. 5.7.3 South America Bendamustine Hydrochloride for Injection Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Bendamustine Hydrochloride for Injection Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Bendamustine Hydrochloride for Injection Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Bendamustine Hydrochloride for Injection Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Bendamustine Hydrochloride for Injection Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Bendamustine Hydrochloride for Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Bendamustine Hydrochloride for Injection Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Bendamustine Hydrochloride for Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Bendamustine Hydrochloride for Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Bendamustine Hydrochloride for Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Bendamustine Hydrochloride for Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Bendamustine Hydrochloride for Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Bendamustine Hydrochloride for Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Bendamustine Hydrochloride for Injection Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Bendamustine Hydrochloride for Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Bendamustine Hydrochloride for Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Bendamustine Hydrochloride for Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Bendamustine Hydrochloride for Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Bendamustine Hydrochloride for Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Bendamustine Hydrochloride for Injection Value Chain Analysis
  2. 8.1.1 Bendamustine Hydrochloride for Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Bendamustine Hydrochloride for Injection Production Mode & Process
  5. 8.2 Bendamustine Hydrochloride for Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Bendamustine Hydrochloride for Injection Distributors
  8. 8.2.3 Bendamustine Hydrochloride for Injection Customers
9 Global Bendamustine Hydrochloride for Injection Analyzing Market Dynamics
  1. 9.1 Bendamustine Hydrochloride for Injection Industry Trends
  2. 9.2 Bendamustine Hydrochloride for Injection Industry Drivers
  3. 9.3 Bendamustine Hydrochloride for Injection Industry Opportunities and Challenges
  4. 9.4 Bendamustine Hydrochloride for Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst